Viewing Study NCT02225002


Ignite Creation Date: 2025-12-25 @ 3:52 AM
Ignite Modification Date: 2026-03-04 @ 11:13 AM
Study NCT ID: NCT02225002
Status: COMPLETED
Last Update Posted: 2018-08-28
First Post: 2014-08-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors
Sponsor: Abramson Cancer Center at Penn Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module